National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, China.
Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
J Clin Lab Anal. 2022 Jan;36(1):e24139. doi: 10.1002/jcla.24139. Epub 2021 Nov 23.
Quality control materials are necessary for assay development, test validation, and proficiency testing in cancer mutation analysis. Most of the existing controls for somatic mutations only harbor a single variant and are derived from unstable cell lines. This study aimed to establish a method to create stable multianalyte controls in a defined background by genome editing in GM12878 cells, which also can be applied for the reference of next-generation sequencing.
GM12878 cells were electroporated with a donor plasmid containing a mutant DNA sequence and a Cas9/sgRNA expressing vector. The genome-edited GM12878 cell was validated with Sanger sequencing, amplification refractory mutation system (ARMS), and next-generation sequencing (NGS).
We have successfully generated a mutant GM12878 cell line harboring the defined variants including single-nucleotide variants (SNVs), small insertions and deletions (indels), and structural variants (SVs). The introduction of intended mutations in GM12878 cell line was confirmed by both ARMS and sequencing methods.
We developed a method for the preparation of the multiplexed controls for reference mutations in cancer gene by genome editing in GM12878 cells. This methodology can be used to generate other stable cancer reference materials with an unlimited supply.
质量控制材料对于癌症突变分析中的检测开发、测试验证和能力验证是必要的。现有的大多数体细胞突变对照品仅携带单一变异,且源自不稳定的细胞系。本研究旨在建立一种通过 GM12878 细胞中的基因组编辑创建稳定的多分析物对照品的方法,该方法也可用于下一代测序的参考。
将包含突变 DNA 序列和 Cas9/sgRNA 表达载体的供体质粒电穿孔到 GM12878 细胞中。使用 Sanger 测序、扩增不可检出突变系统 (ARMS) 和下一代测序 (NGS) 对基因组编辑的 GM12878 细胞进行验证。
我们成功地生成了携带定义变异的突变 GM12878 细胞系,包括单核苷酸变异 (SNVs)、小插入和缺失 (indels) 和结构变异 (SVs)。通过 ARMS 和测序方法均证实了 GM12878 细胞系中预期突变的引入。
我们开发了一种通过 GM12878 细胞中的基因组编辑制备癌症基因参考突变的多重对照品的方法。该方法可用于生成其他具有无限供应的稳定的癌症参考材料。